Overview
Also known as:
FDA & Trial Timeline
2 eventsNovartis Pharmaceuticals — PHASE3
Novartis Pharmaceuticals — PHASE3
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Atypical hemolytic uremic syndrome with anti-factor H antibodies.
2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for Atypical hemolytic uremic syndrome with anti-factor H antibodies.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Atypical hemolytic uremic syndrome with anti-factor H antibodies.
Community
No community posts yet. Be the first to share your experience with Atypical hemolytic uremic syndrome with anti-factor H antibodies.
Start the conversation →Latest news about Atypical hemolytic uremic syndrome with anti-factor H antibodies
No recent news articles for Atypical hemolytic uremic syndrome with anti-factor H antibodies.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Atypical hemolytic uremic syndrome with anti-factor H antibodies
Are there clinical trials for Atypical hemolytic uremic syndrome with anti-factor H antibodies?
Yes — 2 recruiting clinical trials are currently listed for Atypical hemolytic uremic syndrome with anti-factor H antibodies on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.